These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 23356023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The Forthcoming History of Leprosy].
    Hundeiker M, Bassukas ID.
    Pneumologie; 2016 Dec; 70(S 02):S174-S179. PubMed ID: 27926964
    [No Abstract] [Full Text] [Related]

  • 3. Does dapsone resistance really matter in the MDT era?
    Ji B.
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract] [Full Text] [Related]

  • 4. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five?
    Kumarasinghe SP, Kumarasinghe MP.
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP, Mistry NF, Uplekar MW, Antia NH, Pai VV, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract] [Full Text] [Related]

  • 7. [Drug resistance of Mycobacterium leprae].
    Pattyn SR.
    Acta Leprol; 1986 Dec; 4(3):279-87. PubMed ID: 3551466
    [No Abstract] [Full Text] [Related]

  • 8. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD, Katoch VM.
    Indian J Lepr; 1999 Dec; 71(4):451-63. PubMed ID: 10804973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dr. Jacinto Convit (1913-2014).
    Paniz Mondolfi AE, Bloom BR.
    Am J Trop Med Hyg; 2014 Aug; 91(2):435-436. PubMed ID: 25100791
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
    Sansarricq H.
    Acta Leprol; 1986 Aug; 4(3):355-62. PubMed ID: 3551474
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP). Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):864-71. PubMed ID: 3325580
    [No Abstract] [Full Text] [Related]

  • 15. An appraisal of medical research in the treatment and control of leprosy.
    Rees RJ.
    Lepr India; 1982 Oct; 54(4):783-800. PubMed ID: 6763969
    [No Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM, Strong LC, Meindl W, Schoenenberger H, Gardner GD.
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [Abstract] [Full Text] [Related]

  • 17. History of chemotherapy of leprosy.
    Noordeen SK.
    Clin Dermatol; 2016 Mar; 34(1):32-6. PubMed ID: 26773621
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Primary dapsone resistant Mycobacterium leprae in a non endemic country.
    Jamil A, Noor NM, Osman AS, Baseri MM, Muthupalaniappen L.
    Indian J Dermatol Venereol Leprol; 2013 Mar; 79(4):527-9. PubMed ID: 23760326
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.